NOTCH1 and hepatocellular carcinoma: At the same time, overexpression of miR-760, normally suppressed by doxorubicin treatment, mitigated HCC resistance to this chemotherapeutic drug through inhibiting Notch1 and promoting PTEN expression, demonstrating that inhibition of Notch1 might be re-sensitizing in this tumor as well [506].